This study evaluates the association of sociodemographic and health care factors with enrollment in a tobacco-cessation randomized controlled trial (Screen ASSIST) among individuals undergoing lung cancer screening (LCS).
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Prevalence of Cannabis Use Among People Who Smoke Cigarettes and Are Scheduled for Lung Cancer Screening
Cannabis use in the US is increasing in prevalence among older adults and people who smoke cigarettes. Little is known about rates of use among adults 50 to 80 years old undergoing lung cancer screening (LCS). The current study aimed to characterize the prevalence and correlates of cannabis use among adults 50 to 80 years old at high risk for lung cancer.
-
Opportunities for Predicting Lung Cancer Screening Nonadherence: A Systematic Review and Meta-Analysis
The low adherence rate to annual lung cancer screening (LCS) reduces potential mortality benefits. Interventions to improve adherence often do not consider individualized risk for nonadherence, which is vital in informing the design of tailored interventions. The authors systematically reviewed the literature and conducted a meta-analysis on predicting LCS nonadherence risk using machine learning.
-
REACHing for Patient-Centered Screening: Leveraging Mammography Pathways to Advance Lung Cancer Prevention
Lung cancer remains the deadliest cancer in the United States, yet most individuals eligible for its only proven screening modality, low-dose CT (LDCT), never undergo it. Although LDCT reduces lung cancer mortality by up to 20%, national uptake has stalled at about 16% for more than a decade [1]. The barriers are multifactorial, encompassing stigma, misinformation, and limited engagement at the point of eligibility [1]. But perhaps the question is not only whom we reach, but where we reach them.
-
Proactive, Prediction-Driven Outreach for Lung Cancer Screening: Development and Feasibility of a Population Management Toolkit
A prediction-driven approach to population management and proactive outreach is feasible and acceptable to clinicians and patients. Further studies should test the impact of this approach on LCS uptake and outcomes.
-
“You Always Worry”: Scan-Related Anxiety Among Patients With Metastatic Lung Cancer
Routine cancer scans (eg, CT, MRI) produce important prognostic information. However, patients may experience distressing “scanxiety” around the time of scans and scan result discussions. The aim of this study was to describe scanxiety and factors affecting it among patients with metastatic lung cancer completing disease-monitoring, postdiagnosis scans.
-
Reliability of Electronic Medical Record to Assess Patient’s Eligibility for Lung Cancer Screening: Analysis of Two Pilot Trials
Accurate smoking history documentation in electronic medical records (EMRs) is essential for determining lung cancer screening (LCS) eligibility. We investigated the completeness of EMR smoking data, its concordance with patients’ self-reports, and its reliability for LCS eligibility after 2021 LCS United States Preventive Services Task Force guideline change.
-
What a Peer-Led, Community-Engaged Lung Cancer Screening Pilot Study Taught Us About Reaching Black Veterans
Despite high lung cancer risk, Black Americans have disproportionately low lung cancer screening (LCS) uptake. This low uptake is driven by low LCS awareness, mistrust of the health care system, lung cancer-related stigma and fatalism, health-related social needs, and structural racism [1,2]. To overcome these barriers to LCS uptake, tailored implementation strategies that meaningfully engage Black communities are needed.